Somnomed Limited

Last Updated:
3:55 pm
Friday, July 18, 2025
SomnoMed Ltd. engages in the production and sale of devices for the oral treatment of sleep related disorders. Its products include SomnoDent, SomMorning Repositioner, SomnoBrux, SomTabs, and Sunrise Sleep Test. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded in 2004 and is headquartered in Sydney, Australia.
Market Cap
AU$136.15M
Volume
17295
Open
0.65
AU$
High
0.65
AU$
Low
0.65
AU$
Shares On Issue
216M
52 Week Low
0.24
AU$
52 Week High
0.695
AU$
Website
Sector
Healthcare
Medical Specialties
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report

Related

Our friendly team is here to help.

If you have any questions or feedback about our service, please feel free to contact us.